Mclean Hospital
Clinical trials sponsored by Mclean Hospital, explained in plain language.
-
Keto diet shows promise for bipolar disorder in early trial
Disease control ENROLLING_BY_INVITATIONThis 12-week study is for people who completed a previous trial of the ketogenic diet for first-episode bipolar disorder. Researchers want to see if the diet can improve symptoms like depression, mania, and psychosis, as well as brain energy metabolism and insulin resistance. Abo…
Phase: NA • Sponsor: Mclean Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could matching daily choices cut dementia agitation?
Symptom relief TerminatedThis study tests whether a structured conversation between people with dementia or mild cognitive impairment and their care partners can reduce difficult symptoms like agitation and depression. The idea is that when care partners better understand the person's everyday preference…
Phase: NA • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
CBD spray calms Alzheimer's anxiety? early trial hints at relief
Symptom relief OngoingThis small, early-stage study tested a high-CBD, low-THC liquid spray for 8 weeks in 12 older adults with mild cognitive impairment or mild-to-moderate Alzheimer's who also had significant anxiety or agitation. The goal was to see if the treatment could reduce these behavioral sy…
Phase: EARLY_PHASE1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Brain scans reveal hidden scars of childhood abuse in women
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how childhood abuse and neglect change the brain in women with PTSD or dissociative identity disorder. Researchers will use MRI scans and cognitive tests to measure brain activity related to attention, emotions, and feelings of detachment. The goal is to bette…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
1600 people with opioid addiction to be tracked for years to uncover secrets of recovery
Knowledge-focused OngoingThis study follows 1600 adults with opioid use disorder over the long term by collecting monthly online surveys and yearly phone interviews. Researchers will track substance use, mental health, treatment involvement, and daily functioning. The goal is to better understand how peo…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Brain scans reveal how gentle magnets affect bipolar depression in seniors
Knowledge-focused OngoingThis study looks at how low field magnetic stimulation changes brain activity in older adults (age 60+) with bipolar depression. Forty participants receive both real and sham (fake) stimulation on separate days, with brain scans taken before and after each session. The goal is to…
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Brain scans may predict depression relapse
Knowledge-focused OngoingThis study looks at how people who have had major depression in the past make decisions when faced with choices that involve risk or reward. Researchers use brain scans (MRI) and computer tasks to understand which brain areas are involved. The goal is to find patterns that might …
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Cocaine cure study pulled before it even started
Knowledge-focused TerminatedThis study was designed to test whether a drug called lorcaserin could help people with cocaine dependence by rebalancing serotonin in the brain. Researchers planned to use brain scans to see if the drug reduced cravings and impulsivity. However, the study was withdrawn before en…
Phase: PHASE1 • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Could a brain chemical blocker prevent Stress-Linked depression?
Knowledge-focused TerminatedThis study aimed to see if a drug called LY-2940094 could protect healthy adults from developing depression- or anxiety-like symptoms after stress. Researchers planned to give the drug to participants and then measure their brain responses to rewards and fear. However, the trial …
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC